Acuitas: noun, insight, perception, sharpness.

Pieter Cullis Ph.D. Board Chair and Scientific Advisor

peter-cullisDr. Cullis is the Life Sciences Institute Director, Professor, Department of Biochemistry and Molecular Biology and Director, NanoMedicines Research Group at the University of British Columbia. Dr. Cullis and co-workers have been responsible for fundamental advances in the generation, loading and targeting of liposomal nanoparticulate (LNP) systems for intravenous delivery of conventional and nucleic acid drugs. This work has contributed to three LNP products that have been approved by regulatory agencies in the U.S. and Europe. He has published over 290 scientific articles and is an inventor on over 40 patents. Dr. Cullis has received many awards, including the B.C. Science Council Gold Medal, the Alec D. Bangham Award and the B.C. Biotechnology Association award for Innovation and Achievement. He was elected a Fellow of the Royal Society of Canada in 2004 and was awarded the Prix Galien, Canada’s premier prize for achievements in pharmaceutical R&D, in 2011.

Our History

Acuitas Therapeutics is a private company incorporated in British Columbia, Canada. We were founded in February 2009 (initially as AlCana Technologies) and have partnered with Alnylam Pharmaceuticals, the University of British Columbia, IRAP and others on several research and development programs relating to systemic delivery of nucleic acid therapeutics.
Contact Information

Twitter Feed

Find out what's happening, right now, with Acuitas Therapeutics.

Copyright 2018 Acuitas Therapeutics. Web Design by Tommy Le Inc.